DSM-Firmenich


Running down

13/02/20 -"Or perfect timing. The reported 2019 figures were not bad and broadly confirmed our view on the company and the street’s expectations. But they were not glittering like at other companies when ..."

Pages
67
Language
English
Published on
13/02/20
You may also be interested by these reports :
11/07/25
Our increased optimism for our 2025 projections arises from the minimal impact of the global conflict on gas futures and current prices. We had ...

11/07/25
Strong profit figures despite FX headwind, due to favorable mix effect

10/07/25
The EPS forecast for 2025/26 has been adversely affected by the assumption of higher interest rates, as some costs may not be tax-deductible. In the ...

09/07/25
We have integrated the latest figures and adopted a more cautious outlook for 2025, as the chemicals sector remains challenged. The anticipated ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO